Predictive Oncology Inc. (POAI)
NASDAQ: POAI · Real-Time Price · USD
1.480
+0.210 (16.54%)
At close: Jan 22, 2025, 4:00 PM
1.460
-0.020 (-1.35%)
After-hours: Jan 22, 2025, 4:56 PM EST

Predictive Oncology Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2014
Period Ending
Jan '25 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2014
Market Capitalization
101324621310
Upgrade
Market Cap Growth
-59.24%-44.64%-61.32%382.16%26.38%17.42%
Upgrade
Enterprise Value
95-1221816
Upgrade
Last Close Price
1.273.296.1319.0414.6552.20
Upgrade
PS Ratio
4.117.5116.0443.9410.347.26
Upgrade
PB Ratio
4.311.621.111.554.900.91
Upgrade
P/TBV Ratio
3.011.671.122.12--
Upgrade
EV/Sales Ratio
6.372.59-15.2614.3911.01
Upgrade
Debt / Equity Ratio
1.220.350.010.022.220.49
Upgrade
Asset Turnover
0.120.090.040.050.070.11
Upgrade
Inventory Turnover
1.701.371.231.441.862.47
Upgrade
Quick Ratio
0.932.295.778.810.100.04
Upgrade
Current Ratio
1.202.556.029.090.160.07
Upgrade
Return on Equity (ROE)
-201.46%-93.11%-82.98%-91.62%-373.14%-343.66%
Upgrade
Return on Assets (ROA)
-66.44%-43.34%-27.46%-29.63%-44.04%-62.86%
Upgrade
Return on Capital (ROIC)
-88.93%-52.61%-30.25%-33.91%-61.74%-88.90%
Upgrade
Earnings Yield
-137.86%-104.61%-106.59%-31.49%-199.94%-189.28%
Upgrade
FCF Yield
-129.65%-100.73%-52.97%-21.02%-96.99%-85.30%
Upgrade
Buyback Yield / Dilution
-20.51%-8.92%-34.34%-359.21%-316.36%-123.95%
Upgrade
Total Shareholder Return
-20.51%-8.92%-34.34%-359.21%-316.36%-123.95%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.